What did Xtant Medical Holdings, Inc pay for Surgalign Coflex and Cofix Products?

Xtant Medical Holdings, Inc acquired Surgalign Coflex and Cofix Products for $17.0M in 2023, equivalent to 1.20x revenue. Target revenue was approximately $14.0M.

What does Surgalign Coflex and Cofix Products do?

Surgalign Coflex and Cofix Products is a medical devices business.

What multiple did Xtant Medical Holdings, Inc pay for Surgalign Coflex and Cofix Products?

1.20x revenue, based on disclosed deal value of $17.0M and disclosed financials.

M&A TRANSACTION · 2023

Surgalign Coflex and Cofix Products acquired by Xtant Medical Holdings, Inc

$17.0M· 1.20x revenue

Target

Surgalign Coflex and Cofix Products

Acquirer

Xtant Medical Holdings, Inc

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$14.0M

EBITDA

—

Deal Value

$17.0M

EV/EBITDA

—

Context

This $17.0M acquisition of Surgalign Coflex and Cofix Products by Xtant Medical Holdings, Inc sits in the medical devices sub-vertical. Xtant Medical Holdings, Inc is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Surgalign Coflex and Cofix Products acquisition.

Citation: ExitValue.ai. (2023). Surgalign Coflex and Cofix Products acquired by Xtant Medical Holdings, Inc. https://exitvalue.ai/deals/surgalign-coflex-and-cofix-products-acquired-by-xtant-medical-holdings-inc-hc-2023-0051